Wednesday, February 6, 2013

Alpha Szenszor, Technion to commercialize non-invasive Lung cancer test

Another miracle from the nation that specializes in them.
From Israel 21C:

Alpha Szenszor, a leading provider of carbon nanotube (CNT) based sensors, and the Technion-Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection from human breath. They hope their combined expertise will lead to commercializing an economically viable, non-invasive, digital tool for the early diagnosis of lung cancer....

At Technion, we are excited by this new venture with Alpha Szenszor. The combination of strengths and expertise of both parties will greatly enhance our ability to save human lives,” says lead researcher Prof. Hossam Haick, of the Technion Department of Chemical Engineering. “The Technion’s and Alpha Szenszor’s strong IP portfolio and experience will enable the fast and effective transition of this valuable technology from the lab to the medical world where it will be of real benefit in the fight against cancer

What Israel 21C doesn't mention is that Prof Hossam Haick is one of the most distinguished young scientists in Israel.  

From his faculty page at the Technion website:

Prof. Haick has received several awards for his research, including a Knight of the Order of Academic Palms (Chevalier dans l'Ordres des Palmes Académiques), the list of the world’s 35 leading young scientists for 2008 of the prestigious scientific journal MIT’s Technology Review, the Horev Chair for Leaders in Science and Technology, the "Innovation and Entrepreneurship" Prize in Chemical Engineering, the Discovery Program Award of the Bill & Melinda Gates Foundation, the OXYGEN Prize, the Norman and Barbara Seiden Prize, the Israel-France Award for Academic Excellence, the Herschel Rich Innovation Award (2008, 2011), the Minerva Short-Term Research Award, the Bergmann Award for Excellent Young Scientists, the CREATE Award, the Al-Qendil Prize, and the YMCA and Rotary Honorary Decorations.  In addition, Prof. Haick was selected for the lists of “Ten Most Promising Young Israeli Scientists” of Calcalist (2010), “Young Israelis of the Year” of the Jerusalem Post” (2010), “50 Leading Israelis for 2007” and “four saluted Israeli scientists” (2007) of Yedioth Aharonot.  Other honors and awards include the Fulbright fellowship, ‘Israel Ministry of Science and Technology' awards, Prof. Avrahami prize, and CNR-IMIP prize.
Besides his recent and past achievements in research, he had excellent achievements as a lecturer, expressed by a wide variety of prizes that he received for (constantly) excellence in teaching (top 4%). Prof. Haick is the recipient of the prestigious "Yanai Prize for Academic Excellence", which is given for exceptional and significant contribution in teaching and academic education. Prof. Haick had also worked as a supervisor for a broad range of talented graduate and undergraduate students worldwide. Prof. Haick serves as an associate editor of the Journal of Translational Engineering in Health and Medicine, review editor of the Frontiers in Pharmacology of Anti-Cancer Drugs, and member of the editorial board of several peer-reviewed journals, such as Journal of Nanoscience Letters, Hybrid Materials, Dataset Papers in Physical Chemistry, Frontiers in Respiratory Pharmacology, etc. Prof. Haick serves as an advisory consultant to the Chemical Abstracts Service (CAS) – the world's authority for chemical information - a senior scientific advisory member of several national and international companies and institutes, and as a scientific evaluator in the European Commission.

And incidentally, Prof. Haick is an Israeli Arab.

No comments: